Kazia Therapeutics (KZIA) Current Deferred Revenue (2016 - 2018)
Kazia Therapeutics (KZIA) posted Current Deferred Revenue of $104471.1 for Q2 2018, up 239.2% on a QoQ basis from $30799.6 in Q2 2017, and up 239.2% year-over-year from $30799.6 in Q2 2017.
Kazia Therapeutics (KZIA) Current Deferred Revenue (2016 - 2018) Analysis & Trends
Kazia Therapeutics' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $104471.1 for Q2 2018.
- Quarterly Current Deferred Revenue rose 239.2% year-over-year to $104471.1 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $104471.1 (up 239.2% YoY) and the FY2018 annual result came in at $104471.1, up 237.91% from the prior year.
- Current Deferred Revenue was $104471.1 for Q2 2018 at Kazia Therapeutics, up from $30799.6 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $137892.6 in Q4 2016 and bottomed at $30617.0 in Q2 2016.
- A 3-year average of $75945.1 and a median of $67635.4 in 2017 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2017 — Current Deferred Revenue gained 0.6% — and 2018, when it soared 239.2%.
- Kazia Therapeutics' Current Deferred Revenue stood at $137892.6 in 2016, then slumped by 77.66% to $30799.6 in 2017, then surged by 239.2% to $104471.1 in 2018.
- Business Quant data shows KZIA's Current Deferred Revenue at $104471.1 in Q2 2018, $30799.6 in Q2 2017, and $137892.6 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 104,471.09 |
| Jun 30, 2017 | 30,799.62 |
| Dec 31, 2016 | 137,892.62 |
| Jun 30, 2016 | 30,617.04 |